| 发明名称 |
MEDICINAL COMPOSITION |
| 摘要 |
<p><P>PROBLEM TO BE SOLVED: To provide a medicinal composition containing a pyrazolo[1,5-a]pyrimidine compound having a CB1 receptor-antagonizing action as an active ingredient. <P>SOLUTION: This medicinal composition comprises a compound represented by general formula [I] (wherein, R<SP>1</SP>and R<SP>2</SP>are an aryl group or the like; Q is a single bonding group; the ring A is a substituted pyrazole ring condensed with the adjacent pyrimidine ring; R<SP>3</SP>is identically or differently H or the like) or its pharmacologically acceptable salt as an active ingredient. <P>COPYRIGHT: (C)2009,JPO&INPIT</p> |
| 申请公布号 |
JP2008285482(A) |
申请公布日期 |
2008.11.27 |
| 申请号 |
JP20080108647 |
申请日期 |
2008.04.18 |
| 申请人 |
MITSUBISHI TANABE PHARMA CORP |
发明人 |
MORITANI YASUNORI;SHIRAI KIMIHIRO;OI MARIKO |
| 分类号 |
A61K31/519;A61K31/5377;A61K31/541;A61K31/55;A61K45/00;A61P1/00;A61P1/04;A61P1/08;A61P1/12;A61P1/14;A61P1/16;A61P3/04;A61P3/06;A61P3/10;A61P9/00;A61P9/02;A61P9/10;A61P9/12;A61P11/06;A61P13/00;A61P15/08;A61P23/00;A61P23/02;A61P25/00;A61P25/02;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P25/34;A61P25/36;A61P27/06;A61P29/00;A61P31/00;A61P35/00;A61P37/02;A61P39/02;A61P43/00;C07D487/04;C07D519/00 |
主分类号 |
A61K31/519 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
